Overview
- 106 inspections across 103 sites are on record.
- 385 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-04-20.
At a glance
Inspections
106
Sites
103
Observations
385
Career since
Jun 2016
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Paxeuticals LLC | 20 Apr 2026 | Human Drugs | On file |
| Cerovene Inc. | 23 Mar 2026 | Human Drugs | On file |
| Fresenius Kabi USA, LLC | 13 Feb 2026 | Human Drugs | On file |
| Optimus Drugs Private Limited | 19 Dec 2025 | Human Drugs | On file |
| Optimus Pharma Private Limited | 11 Dec 2025 | Human Drugs | On file |
Sites inspected
Paxeuticals LLCParsippany, United States1 insp.
Cerovene Inc.Valley Cottage, United States1 insp.
Fresenius Kabi USA, LLCWilson, United States1 insp.
Optimus Drugs Private LimitedBhongiri, India1 insp.
Optimus Pharma Private LimitedSangareddy, India1 insp.
Co-investigators
Investigators who share inspections with this person.
Kellia N Hicks4 shared
Guerlain Ulysse4 shared
Dipesh K Shah3 shared
Jessica S Estriplet3 shared
Jogy George3 shared
Kenneth H Williams3 shared
Gianine E Tompkins3 shared
Jose A Cruz Gonzalez3 shared
Ankur C Patel2 shared
Lata C Mathew2 shared
Full investigator report
Get the verbatim findings behind Yvins Dezan's 385 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site